SCHIANO MORIELLO, NICOLA
 Distribuzione geografica
Continente #
AS - Asia 1.665
NA - Nord America 1.313
EU - Europa 960
SA - Sud America 136
Continente sconosciuto - Info sul continente non disponibili 45
AF - Africa 35
OC - Oceania 3
Totale 4.157
Nazione #
US - Stati Uniti d'America 1.239
SG - Singapore 627
RU - Federazione Russa 446
CN - Cina 403
VN - Vietnam 269
IT - Italia 234
HK - Hong Kong 125
BR - Brasile 103
BD - Bangladesh 74
DE - Germania 72
FR - Francia 52
NL - Olanda 41
JP - Giappone 38
CA - Canada 37
KR - Corea 36
GB - Regno Unito 30
IN - India 27
FI - Finlandia 20
AR - Argentina 15
MX - Messico 15
PL - Polonia 14
UA - Ucraina 8
ZA - Sudafrica 8
ES - Italia 7
MA - Marocco 7
SE - Svezia 7
CI - Costa d'Avorio 6
EC - Ecuador 6
SA - Arabia Saudita 6
ID - Indonesia 5
LT - Lituania 5
NP - Nepal 5
PH - Filippine 5
PK - Pakistan 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CH - Svizzera 4
IE - Irlanda 4
IQ - Iraq 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AL - Albania 3
CO - Colombia 3
CR - Costa Rica 3
EG - Egitto 3
JM - Giamaica 3
JO - Giordania 3
MY - Malesia 3
NI - Nicaragua 3
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
TR - Turchia 2
UZ - Uzbekistan 2
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.112
Città #
Singapore 321
San Jose 253
Hefei 208
Ashburn 185
Hong Kong 120
Moscow 115
Naples 81
Ho Chi Minh City 75
Beijing 74
Council Bluffs 67
Santa Clara 53
Hanoi 50
The Dalles 49
Los Angeles 40
New York 36
Tokyo 35
Seoul 34
Lauterbourg 30
Munich 28
Rome 27
Amsterdam 25
Chandler 23
Dallas 21
Buffalo 16
Da Nang 14
Orem 14
Redondo Beach 14
Phoenix 13
São Paulo 13
Bologna 11
Frankfurt am Main 11
Turku 11
Haiphong 10
Montreal 10
Nuremberg 10
Toronto 10
Warsaw 10
Atlanta 9
Chicago 9
Houston 9
Seattle 9
Brooklyn 8
Biên Hòa 7
Fisciano 7
Mexico City 7
Milan 7
Boston 6
Helsinki 6
Stockholm 6
Denver 5
Hải Dương 5
Lawrence 5
London 5
Can Tho 4
Catania 4
Charlotte 4
City of London 4
Dublin 4
Düsseldorf 4
Guangzhou 4
Millbury 4
Poplar 4
Rio de Janeiro 4
San Francisco 4
St Louis 4
Amman 3
Baghdad 3
Bangkok 3
Belo Horizonte 3
Bình Phước 3
Cairo 3
Casablanca 3
Chennai 3
Guayaquil 3
Johannesburg 3
Kuala Lumpur 3
Lappeenranta 3
Managua 3
Manchester 3
Mumbai 3
Palermo 3
Paris 3
Parma 3
Querétaro 3
Roubaix 3
Tampa 3
Treia 3
Turin 3
Uta 3
Washington 3
Addis Ababa 2
Afragola 2
Barquisimeto 2
Bengaluru 2
Bern 2
Bertioga 2
Birmingham 2
Bắc Giang 2
Bến Tre 2
Cagliari 2
Totale 2.370
Nome #
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study) 187
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 166
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 165
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 162
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 148
Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves? 148
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 147
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 144
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 144
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 143
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 143
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 139
Risk of professional accidental exposure to biological agents in health care workers: a retrospective analysis carried out in a southern Italian tertiary hospital 139
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 138
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 138
Treatment of Carbapenem-Resistant Acinetobacter baumannii in Real Life (T-ACI): A Prospective Single-Center Observational Study 136
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 136
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy 132
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge 131
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience 130
Measles in pregnant women: A systematic review of clinical outcomes and a meta-analysis of antibodies seroprevalence 128
Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused 126
Update on the Management of Surgical Site Infections 126
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients 121
Effectiveness and Tolerability of Early Treatment with Monoclonal Antibodies against SARS-Cov-2: Results from A Real-Life Study before Omicron Surge 114
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center 110
Pharmacological approaches to prevent vertical transmission of HIV and HBV 105
Re: Persistent COVID-19 in immunocompromised patients-Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al 89
Personalized care approaches to hepatitis C therapy: recent advances and future directions 74
Disentangling the association of hydroxychloroquine treatment with mortality in Covid-19 hospitalized patients through Hierarchical Clustering 61
The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel 57
COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination 51
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study) 42
What Drives Mortality in S. maltophilia Bloodstream Infections? An Outcome-Focused Cohort Study of Treatment Strategies and Resistance Profiles 24
Combination antiviral and anti-CMV immunoglobulin therapy for CMV infection: A case-control study 13
Totale 4.157
Categoria #
all - tutte 13.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 0 0 0 0 0 1 2 9 9
2022/2023119 4 7 3 5 16 16 14 13 15 18 7 1
2023/2024136 3 18 20 14 18 21 3 8 13 2 11 5
2024/20251.046 22 5 4 19 41 68 106 62 65 125 401 128
2025/20262.517 251 260 306 275 356 124 265 125 195 152 106 102
2026/2027303 37 100 88 78 0 0 0 0 0 0 0 0
Totale 4.157